Concord Biotech IPO vs Netweb Technologies India IPO

Comparision between Concord Biotech IPO and Netweb Technologies India IPO.

IPO Details

Concord Biotech IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Netweb Technologies India IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

	Concord Biotech IPO	Netweb Technologies India IPO
Logo
Issue Category	Mainline	Mainline
Issue Type	IPO	IPO
Process Type	Book Built Issue	Book Built Issue
Listing At	BSE, NSE	BSE, NSE
Lead Managers	Kotak Mahindra Capital Company Limited Citigroup Global Markets India Private Limited Jefferies India Private Limited	Equirus Capital Private Limited Iifl Securities Ltd
Registrar	Link Intime India Private Ltd	Link Intime India Private Ltd
Market Maker
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor	Anchor Investor	Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Concord Biotech IPO is up to ₹1,551.00 Cr whereas the issue size of the Netweb Technologies India IPO is up to ₹631.00 Cr. The final issue price of Concord Biotech IPO is ₹741.00 per share and of Netweb Technologies India IPO is ₹500.00 per share.

	Concord Biotech IPO	Netweb Technologies India IPO
Face Value	₹1 per share	₹2 per share
Issue Price (Lower)	₹705.00 per share	₹475.00 per share
Issue Price (Upper)	₹741.00 per share	₹500.00 per share
Issue Price (Final)	₹741.00 per share	₹500.00 per share
Discount (Retail)
Discount (Employee)	₹70.00 per share	₹25.00 per share
Market Lot Size	20 shares	30 shares
Fresh Issue Size		41,20,000 shares
Fresh Issue Size (Amount)		up to ₹206.00 Cr
OFS Issue Size	2,09,25,652 shares	85,00,000 shares
OFS Issue Size (Amount)	up to ₹1,551.00 Cr	up to ₹425.00 Cr
Issue Size Total	2,09,25,652 shares	1,26,20,000 shares
Issue Size Total (Amount)	up to ₹1,551.00 Cr	up to ₹631.00 Cr

IPO Timetable

Concord Biotech IPO opens on Aug 04, 2023, while Netweb Technologies India IPO opens on Jul 17, 2023. The closing date of Concord Biotech IPO and Netweb Technologies India IPO is Aug 08, 2023, and Jul 19, 2023, respectively.

	Concord Biotech IPO	Netweb Technologies India IPO
Anchor Bid Date	Aug 03, 2023	Jul 14, 2023
Issue Open	Aug 04, 2023	Jul 17, 2023
Issue Close	Aug 08, 2023	Jul 19, 2023
Basis Of Allotment (Tentative)	Aug 11, 2023	Jul 24, 2023
Initiation of Refunds (Tentative)	Aug 14, 2023	Jul 25, 2023
Credit of Share (Tentative)	Aug 17, 2023	Jul 26, 2023
Listing date (Tentative)	Aug 18, 2023	Jul 27, 2023
Anchor Lockin End date 1	Sep 10, 2023	Aug 23, 2023
Anchor Lockin End date 2	Nov 09, 2023	Oct 22, 2023

Financials

Concord Biotech IPO P/E ratio is 32.29, as compared to Netweb Technologies India IPO P/E ratio of 59.67.

Concord Biotech IPO

Netweb Technologies India IPO

Financial

Concord Biotech IPO Financial Information (Restated Consolidated)
Period Ended	31 Mar 2021	31 Mar 2022	31 Mar 2023
Assets	1,182.55	1,312.80	1,513.98
Revenue	630.75	736.35	888.48
Profit After Tax	234.89	174.93	240.08
Net Worth	999.37	1,103.22	1,290.00
Reserves and Surplus
Total Borrowing	86.35	60.59	31.24

Amount in ₹ Crore

Netweb Technologies India Limited Financial Information (Restated)
Period Ended	Total Assets	Total Revenue	Profit After Tax	Net Worth	Reserves and Surplus	Total Borrowing
31-Mar-20	50.59	157.23	3.91	13.65	7.99	15.23
31-Mar-21	110.20	144.29	8.23	21.82	16.15	30.54
31-Mar-22	148.61	247.94	22.45	44.37	38.71	34.48
31-Mar-23	265.95	445.65	46.94	93.67	83.48	35.60
Amount in ₹ Crore

Promoter Shareholding (Pre-Issue)

44.08%

97.80%

Promoter Shareholding (Post-Issue)

44.08%

75.45%

P/E Ratio

32.29

59.67

Market Cap

₹7752.06 Cr.

₹2803.20 Cr.

ROE

20.06%%

68.01%%

ROCE

24.27%%

64.42%%

Debt/Equity

0.3

EPS

₹20.79

₹9.22

RoNW

20%%

68.01%%

Shares Offered

In the Concord Biotech IPO retail investors (RII) are offered 73,20,479 shares while in Netweb Technologies India IPO retail investors are offered 73,20,479 shares. Qualified institutional buyers (QIB) are offered 41,83,130 shares in Concord Biotech IPO and 25,20,200 shares in Netweb Technologies India IPO.

	Concord Biotech IPO	Netweb Technologies India IPO
Anchor Investor Reserveration	62,74,695 shares	37,80,300 shares
Market Maker Reserveration
QIB	41,83,130 shares	25,20,200 shares
NII	31,37,348 shares	18,90,150 shares
RII	73,20,479 shares	44,10,350 shares
Employee	10,000 shares	19,000 shares
Others
Total	1,46,50,957 shares	88,39,700 shares

Bids Received (Subscription)

Concord Biotech IPO subscribed 24.87x in total, whereas Netweb Technologies India IPO subscribed 90.55x.

	Concord Biotech IPO	Netweb Technologies India IPO
QIB (times)	67.67x	220.69x
NII (times)	16.99x	83.21x
Big NII (times)	19.30x	88.29x
Small NII (times)	12.37x	73.07x
RII (times)	3.78x	19.48x
Employee (times)	24.48x	55.92x
Other (times)
Total (times)	24.87x	90.55x

Compare with others

Concord Biotech IPO	Netweb Technologies India IPO
Aeroflex Industries IPO	Balaji Speciality Chemicals IPO
Pyramid Technoplast IPO	TVS Supply Chain Solutions IPO
India Shelter Finance IPO	Concord Biotech IPO
Balaji Speciality Chemicals IPO	SBFC Finance IPO
TVS Supply Chain Solutions IPO	Yatharth Hospital IPO
SBFC Finance IPO	Utkarsh Small Finance Bank IPO
Yatharth Hospital IPO	Senco Gold IPO
Netweb Technologies India IPO	Cyient DLM IPO
Utkarsh Small Finance Bank IPO	ideaForge Technology IPO
Senco Gold IPO	HMA Agro Industries IPO

Comments

Add a public comment...